Ask for the reason behind the order
There is no single consumer blood-test package that can establish whether every GLP-1 medicine is appropriate for every person. Begin with the proposed medication, the reason for treatment and your medical history. Ask the clinician which tests they want, what question each test answers and whether a result could change the treatment plan. NIDDK describes medication choice as a discussion involving health conditions, other medicines, benefits, risks and cost. Blood work supports that discussion; it does not replace it. A larger panel should not automatically be interpreted as better care, and a shorter panel does not by itself demonstrate an inadequate evaluation. Ask for the clinical explanation.[5]
Bring existing results and a complete medicine list
Before paying for another blood draw, locate your recent reports with the dates, units, laboratory reference ranges and the clinician’s comments. Ask the new practice whether those results are sufficiently current and relevant. Do not send only a cropped normal-or-abnormal badge; the complete report gives the reviewing clinician more context. Include prescriptions, over-the-counter medicines and supplements, plus relevant allergies and prior treatment reactions. Tell the practice which clinician manages any existing diabetes or other chronic condition so responsibilities can be coordinated. The practice may still require repeat testing. The aim is to get an explicit decision about reuse, not to promise that outside results will always satisfy another program’s requirements.[5] Prepare the conversation with our first telehealth appointment checklist.
Understand what A1C and glucose can answer
A1C estimates average blood glucose over roughly three months; a glucose measurement answers a different, more immediate question. NIDDK explains that A1C does not require fasting, while some glucose tests do. Ask for instructions for the entire ordered panel, since another test taken at the same visit may have different preparation requirements. Tell the clinician about conditions that might affect A1C interpretation, such as certain blood disorders or recent blood loss or transfusion. A flagged result is a reason for clinical interpretation and sometimes confirmation, not a diagnosis to make from an online threshold. Ask who will explain the finding and whether any additional evaluation is needed before a prescription decision.[1]
| Test | What it reflects | Preparation question |
|---|---|---|
| A1C | Average glucose over about 3 months | A1C itself does not require fasting; check other ordered tests. |
| Fasting plasma glucose | Glucose after a fasting interval | Follow the laboratory’s fasting instructions. |
| Random plasma glucose | Glucose at the time of collection | Ask why this test is being used and how it will be interpreted. |
Based on NIDDK test descriptions. This is not a recommendation to order all three tests or diagnose yourself from a result. Source: NIDDK: the A1C test and diabetes.
Discuss kidney testing in the context of your history
NIDDK describes two important kidney assessments: a blood test estimating filtration and a urine test looking for albumin. They address different aspects of kidney health, and one should not be mistaken for the other. Whether either is needed in your evaluation depends on your history and the clinician’s judgment. If you already have kidney disease or diabetes, bring the monitoring plan from the practice that manages it. Ask which team will track results over time and where the reports should be sent. Avoid treating a single reassuring result as a permanent clearance. A baseline is a reference point for a clinical plan, not a guarantee against a later problem.[2]
| Assessment | What it checks | Question for the clinician |
|---|---|---|
| Blood test with estimated GFR | How well kidneys filter blood | Do I need a current estimate or can prior results be used? |
| Urine albumin test | Whether albumin is present in urine | Does my medical history call for this separate assessment? |
NIDDK describes these as kidney-disease assessments. Their inclusion here does not mean both are required for every GLP-1 start. Source: NIDDK: chronic kidney disease tests and diagnosis.
Separate thyroid history from routine tumor screening
The Zepbound label contraindicates use with a personal or family history of medullary thyroid carcinoma or MEN 2. That history needs to be discussed directly; an ordinary thyroid-function result cannot substitute for it. The same label says routine calcitonin monitoring or thyroid ultrasound has uncertain value for early detection of medullary thyroid carcinoma. This does not mean thyroid symptoms or existing nodules should be ignored. Ask the clinician whether a thyroid test is addressing symptoms, a known condition or another specific concern. Do not assume every branded GLP-1 start requires a calcitonin test, or that a normal screening result overrides a contraindication in your personal or family history.[4]
Ask how the plan changes once treatment begins
Baseline tests and follow-up tests have different purposes. Wegovy’s label calls for glucose monitoring before and during treatment in people with diabetes, and renal-function monitoring when adverse reactions could cause volume depletion. A fixed subscription calendar cannot describe every patient’s needs. Ask which symptoms should trigger earlier contact and whether your other medicines change the monitoring plan. For example, tell the prescriber if you use insulin or another medicine that can cause low blood sugar; medication review is part of planning, not something a lab panel alone resolves. Obtain a clear contact route for new concerns and ask who will interpret repeat results when more than one practice is involved.[3]
Confirm the collection, review and payment steps
Ask whether the quoted price covers ordering, the specimen collection, the laboratory analysis, clinician interpretation and any repeat appointment. These can be distinct parts of the service. Ask which laboratory you may use, whether it is in your insurance network and how an out-of-range result will be communicated. Find out whether the practice requires results before the first treatment decision and what happens to membership billing while results are pending. Keep the written answer with your quote. Neither the word included nor the phrase labs available tells you the complete cost or review process. Do not interpret a provider’s checkout flow as confirmation that a clinician has reviewed your tests.[5] For a focused price checklist, read GLP-1 lab fees. Compare the complete quote with the two-plan budget calculator after separating laboratory and follow-up charges.
Choose a service with a clear results pathway
A useful care-shopping question is: who takes responsibility for an unexpected result? Ask whether the prescribing clinician reviews it, whether a primary-care referral may be needed and how you will receive a copy. If a finding requires further evaluation, clarify the next step rather than treating the purchase of tests as completion of care. Our PlushCare and Form Health reviews describe different published service models and billing structures that you can compare before enrolling. They are not endorsements of a particular lab panel or a prediction that either practice will prescribe a medicine. Use them to prepare a written question list, then let your clinician determine the testing and treatment appropriate to you.[5] Read the service and visit-cost context in the PlushCare review before asking how labs are billed. For ongoing clinician and dietitian care, compare the Form Health review and confirm current testing and follow-up arrangements.
Put the questions to work
Compare our researched providers or build your provider checklist.
Explore relevant provider reviews
Use these reviews to compare the published services and terms. Inclusion is a research starting point, not a recommendation for treatment.
Continue your research
Sources & scope
Sources checked October 15, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.
- NIDDK: the A1C test and diabetes
- NIDDK: chronic kidney disease tests and diagnosis
- Wegovy: current US prescribing information
- Zepbound: current US prescribing information
- NIDDK: prescription medicines for overweight and obesity
Prices and terms can change. Confirm your specific offer directly with the provider.